During the past decade, UCSF - Division of Hematology/Oncology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "UCSF - Division of Hematology/Oncology" are "Polycythemia Vera" (2 trials), "Myelofibrosis" (1 trials), "Myeloproliferative Disorders" (1 trials) and "Thrombocythemia, Essential" (1 trials). Many other conditions were trialed in "UCSF - Division of Hematology/Oncology" in a lesser frequency.

Most popular intervention types in "UCSF - Division of Hematology/Oncology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "XL019" (2 trials). Other intervention names were less common.

The vast majority of trials in "UCSF - Division of Hematology/Oncology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "UCSF - Division of Hematology/Oncology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in UCSF - Division of Hematology/Oncology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in UCSF - Division of Hematology/Oncology, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".